Nevro Corp NVRO
We take great care to ensure that the data presented and summarized in this overview for NEVRO CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NVRO
View all-
Beryl Capital Management LLC Redondo Beach, CA3.76MShares$22 Million9.16% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$21 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.07MShares$12.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$12.1 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I01.85MShares$10.8 Million0.45% of portfolio
-
Meteora Capital, LLC Boca Raton, FL1.72MShares$10.1 Million7.9% of portfolio
-
Gardner Lewis Asset Management L P Chadds Ford, PA1.63MShares$9.52 Million2.29% of portfolio
-
Gabelli Funds LLC Rye, NY1.32MShares$7.73 Million0.06% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.25MShares$7.31 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.21MShares$7.06 Million0.01% of portfolio
Latest Institutional Activity in NVRO
Top Purchases
Top Sells
About NVRO
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Insider Transactions at NVRO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 03
2025
|
Christofer Christoforou SVP, Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
363,765
-100.0%
|
-
|
|
Apr 03
2025
|
Kashif Rashid SVP, Corp Dev and CLO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
477,738
-100.0%
|
-
|
|
Apr 03
2025
|
Greg Siller SVP & Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
195,598
-100.0%
|
-
|
|
Apr 03
2025
|
Michael F Demane |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
441,755
-100.0%
|
-
|
|
Apr 03
2025
|
Michael F Demane |
SELL
Sale (or disposition) back to the issuer
|
Direct |
61,863
-100.0%
|
-
|
|
Apr 03
2025
|
Elizabeth H Weatherman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
86,171
-100.0%
|
-
|
|
Apr 03
2025
|
Roderick H. Mac Leod SVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
350,663
-100.0%
|
-
|
|
Apr 03
2025
|
Kevin C Oboyle |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,396
-100.0%
|
-
|
|
Apr 03
2025
|
Karen Prange |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,948
-100.0%
|
-
|
|
Apr 03
2025
|
Kevin R Thornal President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
852,337
-100.0%
|
-
|
|
Apr 03
2025
|
Susan E Siegel |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,382
-100.0%
|
-
|
|
Apr 03
2025
|
Susan E Siegel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,579
-100.0%
|
-
|
|
Apr 03
2025
|
Kirt P Karros |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,452
-100.0%
|
-
|
|
Apr 03
2025
|
Shawn Mc Cormick |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,035
-100.0%
|
-
|
|
Apr 03
2025
|
Sridhar Kosaraju |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,575
-100.0%
|
-
|
|
Apr 03
2025
|
D Keith Grossman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
228,552
-100.0%
|
-
|
|
Mar 20
2025
|
Kashif Rashid SVP, Corp Dev and CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
611
-0.43%
|
$3,055
$5.78 P/Share
|
|
Mar 20
2025
|
Kashif Rashid SVP, Corp Dev and CLO |
BUY
Grant, award, or other acquisition
|
Direct |
1,136
+0.8%
|
-
|
|
Mar 20
2025
|
Christofer Christoforou SVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-0.37%
|
$2,290
$5.78 P/Share
|
|
Mar 20
2025
|
Christofer Christoforou SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
852
+0.68%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 37.6K shares |
|---|
| Sale (or disposition) back to the issuer | 3.28M shares |
|---|---|
| Payment of exercise price or tax liability | 142K shares |